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SUMMARY

Mitochondrial distribution and motility are recognized as central to many cellular functions, but their
regulation by signaling mechanisms remains to be
elucidated. Here, we report that reactive oxygen species (ROS), either derived from an extracellular
source or intracellularly generated, control mitochondrial distribution and function by dose-dependently, specifically, and reversibly decreasing
mitochondrial motility in both rat hippocampal primary cultured neurons and cell lines. ROS decrease
motility independently of cytoplasmic [Ca2+], mitochondrial membrane potential, or permeability transition pore opening, known effectors of oxidative
stress. However, multiple lines of genetic and pharmacological evidence support that a ROS-activated
mitogen-activated protein kinase (MAPK), p38a, is
required for the motility inhibition. Furthermore,
anchoring mitochondria directly to kinesins without
involvement of the physiological adaptors between
the organelles and the motor protein prevents the
H2O2-induced decrease in mitochondrial motility.
Thus, ROS engage p38a and the motor adaptor complex to exert changes in mitochondrial motility, which
likely has both physiological and pathophysiological
relevance.
INTRODUCTION
Mitochondrial distribution and transport are central to many
cellular functions, including cell differentiation (Chada and Hollenbeck, 2004), cell division to ensure proper inheritance (Yaffe,
1999), ATP supply at the local sites of demand, and Ca2+ buffering for intracellular Ca2+ homeostasis (Yi et al., 2004; Zucker,
1999). Strategic intracellular mitochondrial distribution depends
on the movement of mitochondria, which is mediated by a complex of proteins first identified in genetic screens performed in
Drosophila melanogaster. The anterograde mitochondrial transport in axons is abolished in either Milton or Miro mutants (Guo
et al., 2005; Stowers et al., 2002); Milton co-immunoprecipitates

with and attaches kinesin to mitochondria through Miro, an outer
mitochondrial membrane (OMM) protein (Glater et al., 2006). In
mammals, mitochondrial motility is mediated by trafficking kinesin proteins (Trak1 and Trak2, Milton homologs) that work as
adaptors between Miro1 and Miro2 (Miro homologs) and dynein
and kinesin motor proteins to allow movement of the organelles
along the microtubules (Brickley et al., 2005; Fransson et al.,
2006; Hirokawa et al., 1991; MacAskill et al., 2009a; Nguyen
et al., 2014).
In the last decade, the mitochondrial motility machinery has
been determined, but the signaling mechanisms underlying the
specificity and the spatio-temporal control of the mitochondrial
movements remained elusive. Mitochondrial membrane potential (Dcm) is central to mitochondrial movement because agents
that depolarize mitochondria inhibit mitochondrial transport (Rintoul et al., 2003; Vanden Berghe et al., 2004; Yi et al., 2004). First,
mitochondria with high Dcm were shown to preferentially move
anterogradely while depolarized ones move retrogradely (Miller
and Sheetz, 2004), but later studies showed no directionality difference between the two populations (Gerencser et al., 2008;
Verburg and Hollenbeck, 2008). Changes in ATP/ADP likely
affect movements because ADP slowly dissociates from the motor to act like an inhibitor. We and others previously showed that
motility is regulated by the cytoplasmic Ca2+ concentration
([Ca2+]c), providing the basis for a homeostatic circuit in which
the organelles decrease their movements along microtubules
at the sites of high [Ca2+]c to locally buffer Ca2+ and contribute
to ATP supply (Brough et al., 2005; Rintoul et al., 2003; Yi
et al., 2004). Ca2+ sensing involves the helix-loop-helix structural
domain (EF) hands of the Miro proteins (MacAskill et al., 2009b;
Saotome et al., 2008; Wang and Schwarz, 2009).
Mitochondria are also a major site for production and scavenging of reactive oxygen species (ROS) that serve as both a
mediator and a regulator of calcium signaling and are relevant
for the control of mitochondrial function. Numerous studies
have described ROS-induced changes in mitochondrial shape
and distribution (Das et al., 2012; De Vos et al., 2007; Fang
et al., 2012; Magrané et al., 2014; Morfini et al., 2013), but these
changes can result from a variety of different mechanisms, and
the effect of ROS on mitochondrial movements has not been
addressed yet.
Here, we tested the hypothesis that ROS target motility to
control mitochondrial dynamics. Alteration of mitochondrial distribution can be detrimental for several tissues, in particular for
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neurons, where impairments of mitochondrial transport machinery result in neurological deficits (Guo et al., 2005; Mattson et al.,
2008; Nguyen et al., 2014) likely as a consequence of less efficient ATP supply and Ca2+ buffering in cell subdomains where
organelles are lacking. We show that ROS exert a regulatory
effect on mitochondrial motility. In both rat hippocampal neurons
and cell lines (H9c2 cells and mouse embryonic fibroblasts
[MEFs]), either external addition or intracellular generation of
ROS decreases mitochondrial motility. The mechanism is dose
dependent, reversible, and does not require permeability transition pore (PTP) opening or Dcm dissipation. In addition, this
effect can occur independent of [Ca2+]c. However, both chemical
and genetic targeting of p38a protects from the decrease
in mitochondrial movements induced by H2O2. Furthermore,
anchoring mitochondria directly to kinesins without involvement
of the physiological adaptors between the organelles and the
motor protein prevents the H2O2-induced decrease in motility,
indicating that ROS likely target the adaptor complex with the
involvement of p38a to control motility of mitochondria.
RESULTS
ROS Induce a Decrease in Mitochondrial Transport in
Neurons
To assess a possible role of ROS in the control of mitochondrial
motility in neurons, we assayed the effects of H2O2, menadione,
and O2, in mito-roGFP1-transfected rat hippocampal neurons
(Figures 1Ai and S1Bi). The redox cycling compound menadione
is a single electron reduced by ubiquinone in the inner mitochondrial membrane and subsequently reduces O2, resulting in
O2, and H2O2 (Eklöw et al., 1981); therefore, it was used to
aggravate endogenous ROS production. A multiplexed assay
(Gerencser and Nicholls, 2008) was applied to follow mitochondrial transport velocities, length, SH redox status of mitoroGFP1, and DJM (Figure 1Aii–v). Velocities were measured
using optical flow and also visualized by kymograms (Figure S1A). To quantify motility, we averaged optical flow for all
visible neurites for each observed neuron. Importantly, this
approach allowed a low rate of imaging at 5 min intervals to minimize photoillumination-induced effects and to record multiple
view fields cyclically, while velocities were calculated from a
pair of frames recorded at each time point.
Both H2O2 (50 mM) and menadione (10 mM) triggered simultaneous oxidation of roGFP and a decrease in the mitochondrial
motility (Figures 1A–1G; Figures S1A–S1E). Increasing H2O2 to
100 mM induced both higher oxidation and inhibition of mitochondrial velocity. When O2, (generated by 5–14 mU/mL

xanthine oxidase with 100 mM xanthine [X/XO]) was used as an
oxidant, a decrease in motility was also observed (Figures 1D
and 1I). Treatment with X/XO had a strong oxidative property
(Figure 1E) but was less effective than H2O2 in inhibiting mitochondrial transport. To control for cell viability, we measured
plasma membrane potential (DJp) in separate experiments by
an anionic plasma membrane potential indicator (PMPI) (Nicholls, 2006) and intracellular [Ca2+] by rhod2 (under our conditions, rhod2 compartmentalized mostly to the cytoplasm) (Figures S1G and S1H). DJp did not depolarize in the first 2 hr of
the exposure to H2O2 (100 mM) and menadione (10 mM). [Ca2+]c
did not elevate for 90 min in the presence of H2O2, while it slightly
but gradually increased with menadione.
Inhibition of Mitochondrial Motility and Mitochondrial
Elongation Induced by ROS Are Triggered
Independently
Mitochondrial fusion-fission dynamics and movements are
mutually coupled (Liu et al., 2009; Mouli et al., 2009). The motility
decrease caused by H2O2 and O2, was accompanied by elongation of neuronal mitochondria (Figures 1Bv, 1G, and 1J), which
then underwent fragmentation, swelling, and membrane depolarization [DJ(m+p); a surrogate for DJm; Figures 1C, 1F, and
1G]. The elongation effect of ROS on mitochondrial morphology
we observed was reproduced for all of the oxidants used, but not
for all concentrations and with some differences in the temporal
scale (Figures 1G and 1J). Notably, cells rapidly convert O2, to
H2O2 by superoxide dismutases, which is then removed by catalase and the glutathione system. Menadione and glutathione
depletion instead induced a prolonged mitochondrial elongation,
which was observed even after 2 hr from the addition of the drug.
Mitochondria appearing visually elongated were also luminally
continuous as indicated by spatially synchronous fluctuations
of DJm, best observable in neurons in the glutathione-depleted
conditions with 1-chloro-2,4-dintrobenzene (CDNB) or ethacrynic acid (see below; Figure S1I). In contrast to shape changes,
the inhibitory effect on mitochondrial motility was universal and
early for H2O2, X/XO, and menadione treatments for all used
concentrations.
To investigate the temporal relationship of the loss of motility,
shape changes, and DJm, we plotted the parameters shown in
Figures 1D, 1F, and 1G against each other pairwise (Figure 1H;
Figures S1J and S1K). In Figure 1H, the measured properties
gradually deviate from the baseline (‘‘start,’’ 100% velocity and
length) as the experiment progresses to the ‘‘end’’
(t = 120 min). H2O2 (50–100 mM) and X/XO (14 mU/mL) treatments resulted in a characteristic track in the velocity-length

Figure 1. ROS Decrease Mitochondrial Transport Velocity in Neurons (See Also Figure S1)
(A–C) A hippocampal neuron expressing mito-roGFP1 loaded in the presence of tetramethylrhodamine, methyl ester (TMRM) at time point 0 (baseline, Ai), 30 min
(Bi), and 3 hr (Ci) after treatment with H2O2. Velocities of mitochondria (measured as optical flow, ii; arrows, motile mitochondria), redox state of mito-roGFP
(expressed as 438/480 fluorescence ratio, iii), and changes in DJM+P (iv) are shown. The mito-roGFP image was also segmented to measure the length of
mitochondria (v; arrows indicate fused mitochondria). The red quadrangle in (i) corresponds to (ii)–(v), and the red dashed outline in (ii)–(v) to a hand-drawn region
of the analysis.
(D–G) Time courses of velocities (D), redox state of mito-roGFP1 (E), DJM+P (F), and mitochondrial length (fiber length) (G). The indicated treatments were present
from t = 40 min. Mock-treated cells (control, gray trace) are shown.
(H) Parametric plot of velocity and mitochondrial length for the indicated treatments using data from (D) and (G).
(I and J) Mean velocities (I) and mitochondrial length (J) at the indicated time after application of the indicated treatments in mito-roGFP1-expressing rat
hippocampal neurons. *p < 0.05; **p < 0.01.
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Figure 2. H2O2 Induces Mitochondrial Motility Inhibition in H9c2 Cells
(A) Measurement of mitochondrial movements in H9c2 cells transfected with mitoYFP and pretreated with Tg in a Ca2+-free medium. Kymograms (lower) before
(60 s), 8 min after (540 s) H2O2, and 1 min (610 s) after CaCl2 additions. Cells were treated with solvent (–) or H2O2 where indicated.
(B) MitoYFP-expressing cells were loaded with fura-2 AM and pretreated as in (A). The upper row images show the site of mitochondrial movement (red: positive
change, green: negative change between sequential images) at each time point. 340 (red) and 380 nm (green) channels of fura-2 are shown (lower row).
(C) Time courses of motility decay (red) and [Ca2+]c (black) recorded simultaneously in the same cells. [Ca2+]c-induced motility inhibition is shown at the end of the
experiment.
(D) Time courses of motility decay after exposure to varying concentrations of H2O2. 100% inhibition was defined by CaCl2 added at the end of the experiment.

(legend continued on next page)

1670 Cell Reports 21, 1667–1680, November 7, 2017

diagram indicating initial motility inhibition with elongation, followed by further deceleration of mitochondria with shortening.
Remarkably, X/XO (5 mU/mL) and myxothiazol + oligomycin
treatments (used to specifically depolarize DJm by inhibiting
complexes III and V of the oxidative phosphorylation) caused
instead partial deceleration with shortening, whereas menadione
distinctly triggered partial deceleration with marked elongation.
Figure S1J shows that the deceleration caused by specific
DJm depolarization by myxothiazol + oligomycin was far less
in extent than the one caused by oxidants, when comparing
them at identical potentials (e.g., at 10 mV depolarization).
Notably, the myxothiazol + oligomycin-triggered shortening
was probably due to swelling rather than fission as it was earlier
shown (Gerencser and Nicholls, 2008; Yuan et al., 2007). Figures
S1J and S1K indicate that H2O2- and menadione-induced inhibition of motility preceded DJm depolarization, when we consider
that DJp was relatively stable in this time period (Figure S1I).
Notably, H2O2-induced DJp hyperpolarization may mask a small
extent of DJm depolarization, but this was not the case for
menadione. In contrast, the start of a gradual DJm+p depolarization preceded shortening of mitochondria. Altogether,
the different velocity-length temporal tracks triggered by the
different oxidants follow independent trends, supporting the
idea that the effectors modulating motility and mitochondrial
fusion-fission are distinct molecular entities.
H2O2-Induced Mitochondrial Motility Inhibition Is Dose
Dependent, Is Not Mediated by Ca2+, and Spares Other
Organelles
To find out whether the ROS sensitivity of motility was a general
cell mechanism and how it was mediated, we used H9c2 myoblasts because mitochondrial motility and its regulation by
Ca2+ have been studied in this model. Cells were transfected
with mitoYFP, and mitochondrial movement response to H2O2
addition was represented as kymograms in Figure S2A. The
number of movement events significantly diminished 10 min
after 200 mM H2O2 addition and drastically dropped down at
20 min (Figure S2B), reproducing what was observed in rat
hippocampal neurons.
To check the possibility that an ROS-induced [Ca2+]c rise was
the inducer of the motility decay, we next employed Ca2+depleted H9c2 cells. Cells were pretreated with thapsigargin
(Tg; 2 mM), an endoplasmic reticulum (ER)/sarcoplasmic reticulum (SR) Ca2+-ATPase inhibitor, in a Ca2+-free extracellular medium to prevent intracellular Ca2+ mobilization and the ensuing
Ca2+ entry. In these conditions, addition of 100 mM H2O2 inhibited motility of mitochondria, which appeared almost all
completely immobile after 8 min (540 s of time-lapse recording)
as shown by the kymograms in Figure 2A. As expected, addition
of 4 mM CaCl2 at the end of the run (610 s) resulted in full inhibition of movements. The inhibitory effect of H2O2 on mitochondrial transport in Ca2+-depleted conditions was also confirmed
using the photoactivatable fluorescent protein technology (Eis-

ner et al., 2014; Liu et al., 2009; Saotome et al., 2008). Here,
the mitochondrial matrix-targeted fluorescent protein is activated in small subregions of the cell, and subsequent time-lapse
images show moving of individual mitochondria to other areas
(Figures S2C and S2D). In control cells, mitochondria with photoactivated content appeared more and more distant from the
photoactivation areas (see images of 540 and 720 s), whereas
in cells treated with 100 mM H2O2, they remained confined to
the photoactivation areas (Figure S2C). Furthermore, when the
photoactivated fluorescence was plotted for the photoactivation
areas, the time-dependent fluorescence decay was suppressed
in H2O2-pretreated cells (Figure S2D). Thus, 100 mM H2O2
inhibited mitochondrial transport in Ca2+-depleted conditions.
To confirm that no [Ca2+]c change was caused by H2O2, we
also loaded cells with fura-2-acetoxymethyl ester (fura-2 AM).
Moving mitochondria are shown in the mitoYFP image as red
and green pixels in which fluorescence between sequential images (12 s interval) was changing over an empirically determined
threshold (Saotome et al., 2008; Yi et al., 2004). The number of
red and green pixels progressively decreased by H2O2
(100 mM) without any change in [Ca2+]c (Figures 2B and 2C). As
expected, CaCl2 (4 mM) addition caused a [Ca2+]c increase
and further decreased motility. Thus, H2O2-induced mitochondrial motility inhibition is independent of a change in [Ca2+]c. It
was also present even at lower concentrations of H2O2, with
the minimum effective concentration being 25 mM and a dosedependent trend (200 mM; 68% ± 0.8%, 100 mM; 60% ± 1.3%,
50 mM; 41% ± 1.8%, 25 mM; 30% ± 1.7%, 12.5 mM; 3.6% ±
2%; n = 8–10) (Figures 2D and 2E).
Because ROS exposure can cause broad changes in the cells,
we tested whether H2O2 also affected the transport of peroxisomes visualized by SKL-DsRed (Figure 2F). As for mitochondrial motility, SKL-DsRed-transfected H9c2 were Ca2+ predepleted, and the time lapse was recorded in Ca2+-free
extracellular medium. H2O2 (100 mM) addition did not affect
movements of peroxisomes as shown by kymograms at time
point 540 s and by traces of motility decay in Figure 2G. As for
mitochondria, addition of 4 mM CaCl2 caused rapid decrease
of peroxisomal motility. Thus, H2O2 targeted mitochondrial
motility without causing a broad organellar transport change.
H2O2 can cause membrane damage that leads to cell death.
To test whether this happened during the time course of our
measurements, we used propidium iodide (PI) exclusion. In
H9c2 cells (or MEFs used in some experiments later on), addition
of H2O2 (100 mM) failed to allow PI entry (Figures S2E and S2F).
By contrast, digitonin, a detergent added at the end of the run,
caused rapid intracellular accumulation of the dye.
Collectively, these results indicate that H2O2-induced targeting of mitochondrial motility is a general cell mechanism and it
specifically impairs mitochondria movements, leaving peroxisomal motility or cell membrane integrity unaffected at least for
the H2O2 doses used here. The H2O2-induced motility decay
takes place independently from [Ca2+]c change and shows a

(E) Motility inhibition at 8 min after application of H2O2.
(F) Measurement of peroxisomal movements in H9c2 cells transfected with SKL-DsRed and pretreated as in (A). Kymograms (lower) before (60 s) and 8 min after
(540 s) H2O2 addition to H9c2 cells.
(G) Time courses of peroxisomal motility decay (red) and [Ca2+]c (black) recorded simultaneously in the same cells.
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Figure 3. Mitochondrial Motility Is Inhibited
by Intracellularly Formed ROS and Is Reversible
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dose-response relationship with the lowest effective concentration of 25 mM.
Endogenous ROS Induce a Decrease in Mitochondrial
Motility
Next, effects of endogenously produced ROS were studied first
by dampening the antioxidant defense. In hippocampal neurons,
glutathione depletion by ethacrynic acid (Vesce et al., 2005),
CDNB (Figure 1I), or monochlorobimane (MCB; Figure S1F)
reduced mitochondrial motility similarly to oxidants. These findings were recapitulated in mitoYFP-expressing H9c2 cells. MCB
becomes fluorescent when it conjugates with glutathione (GSH)
in the cells (MCB F/F0; 26.0 ± 0.7 versus 1.2 ± 0.0 of control;
p < 0.01; Figure 3A); however, because GSH is major natural
scavenger of H2O2, the formation of intracellular MCB-GSH
rapidly depletes GSH, resulting in an increase in intracellular
ROS (Vesce et al., 2005). Upon MCB-GSH conjugation, a significant motility inhibition was observed (72.5% ± 0.9% versus
1672 Cell Reports 21, 1667–1680, November 7, 2017

(A and B) Simultaneous measurement of GSH
conjugation by MCB (A) and motility (mean traces)
(B). MitoYFP-expressing H9c2 cells were pretreated with Tg in a Ca2+-free extra-cellular medium
(ECM); then MCB was applied. Summarized data at
the time point of 15 min after MCB are shown on the
right. *p < 0.01.
(C) MitoYFP-expressing H9c2 cells were loaded
with MitoTrackerRed-CMTRos (MTR) and then
pretreated as in (A). Confocal images (upper panel)
and respective kymograms (lower) for cells
untreated or treated with mCsA (right) are shown.
Photoillumination was applied to the boxed area to
induce intracellular ROS formation. Time courses of
motility for control (black) and photoilluminated
(red) are shown normalized to the baseline.
(D) Mitochondrial motility shown as change in the
number of recorded events, corresponding to (C).
*p < 0.02 versus control.
(E) Numbers of immobile mitochondria at the photoilluminated, adjacent, and far areas of the cell.
MitoYFP-expressing H9c2 cells were loaded and
preincubated as in (C). Immobile mitochondria
were counted 5 min after photoillumination in the
absence (white bars) and presence of MnTE-2-PyP
(black bars). *p < 0.05 versus 5 min.

15.4% ± 0.9% of control; n = 7; p < 0.01;
Figure 3B). Thus, an intracellular ROS
source could reproduce the inhibitory
effect on motility observed by externally
administering H2O2.
To test whether mitochondrial motility
was affected even when intracellular
ROS were restricted to a small area of
the cell, we loaded mitoYFP-expressing
H9c2 cells with MitoTracker Red-CMXRos
(MTR) and used photoillumination to
generate localized intracellular ROS elevation (Figure 3C). Kymograms and plots of motility show a rapid
and drastic effect on motility in the area of photoillumination (Figure 3D). To test whether photoillumination per se was exerting an
inhibitory effect on motility, we counted the number of immobile
mitochondria also in the adjacent area of the cell (Figure 3E). In
the photoilluminated area, the number of immobile mitochondria
was increased to 86.7%. In the area adjacent to the site of ROS
generation, inhibitory effect was still present, even if with a lesser
extent (34.8%). As a control, immobile mitochondria were
counted in an area far away from the photoilluminated one,
and no inhibition of mitochondrial motility was observed (Figure 3E). To further validate the role of ROS in photoillumination-induced motility inhibition, we pre-incubated cells with a
scavenger, Mn(III) tetrakis (N-ethylpyridinium-2-yl) porphyrin
(MnTE-2-PyP) (Figure 3E). Notably, MnTE-2-PyP is a superoxide
dismutase mimetic and thus converts O2, to H2O2. H2O2 is then
more efficiently eliminated by the GSH-dependent mechanisms
than O2, (Jezek and Hlavatá, 2005). The superoxide dismutase
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Figure 4. Mitochondrial Motility Inhibition by H2O2 Is p38a Mediated (See Also Figure S4)
(A and B) MitoYFP-expressing H9c2 cells were pretreated with Tg in a Ca2+-free ECM; then H2O2 was applied in the presence (A) or absence of CsA (B). Motility is
shown at 5 and 20 min exposure of H2O2 (white bars). H2O2 was eliminated by replacing it for catalase (black bars) at 5 min; then the recovery of motility was
monitored. *p < 0.01 versus 5 min, **p < 0.01 versus catalase (+) 20 min.
(C) Graphic representation of ROS-mediated activation of MEK kinases JNK and p38.
(D) Motility decay (calculated as D between H2O2-treated and untreated cells) at the time point of 3 min after H2O2 addition to H9c2 cells. Where indicated, cells
were pretreated with SP600125 or SB202190 for 20 min. Unexpectedly, these inhibitors alone caused some decrease in motility (46% ± 2% for SP600125 and
29% ± 3% for SB202190 versus 5% ± 1% untreated cells), indicating that the treated cells became frail and sensitive to imaging conditions. Nevertheless, H2O2

(legend continued on next page)
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mimetic resulted in attenuation of the photoillumination-induced
motility inhibition, with a decrease in the number of immobile
mitochondria of almost half of non-treated cells in the photoilluminated area and also in the adjacent area (from 34.5% to 5.1%).
Thus, when ROS is produced in a cellular subregion, the motility
inhibition is also spatially confined, suggesting that ROS can
serve as a local factor in the control of motility.
Neither Mitochondrial PTP Opening nor DJm Loss Is
Required for H2O2-Induced Mitochondrial Motility
Inhibition
In mammalian cells, directional mitochondrial movements usually take place along microtubules. We therefore investigated
whether ROS affected the spatial organization of mitochondria
relative to microtubules. In Figure S3A, the confocal images of
mitoDsRed and tubulin GFP co-transfected cells revealed that
H2O2 did not evoke any change in the spatial relationship
between mitochondria and microtubules (Figure S3A).
A main mitochondrial target of oxidative stress is the PTP, the
opening of which commonly causes mitochondrial dysfunction
(Rasola and Bernardi, 2011). Therefore, next it was investigated
whether PTP is involved in the ROS-induced motility inhibition.
Pre-incubation with the selective PTP inhibitor Me-Val-CSA
(mCsA; 5 mM) did not suppress the ROS-dependent mitochondrial motility inhibition (Figures 3C, right panel, and 3D). The
broad PTP/calcineurin inhibitor cyclosporine A (CsA) was also
applied to Ca2+-depleted cells, and the H2O2-induced motility
decay was evaluated (Figures S3B and S3C). CsA did not alter
the H2O2-induced motility inhibition (64.8% ± 1.3% H2O2 alone
versus 60.9% ± 1.3% of H2O2+CsA; n = 37; Figure 3E), confirming that PTP opening was not involved in the phenomenon.
In hippocampal neurons, H2O2 and menadione inhibited
motility before loss of DJm, and in a greater extent than specific
discharging of DJm did. To further test the relationship between
H2O2-induced motility inhibition and depolarization, we
measured DJm in Ca2+-depleted H9c2 cells. H2O2 did not alter
DJm, at least when the motility inhibition became apparent (Figure S3D). In FCCP- and oligomycin-treated cells, dissipation of
DJm was gradually followed by the loss of motility, reflecting
the slower kinetic of cytoplasmic ATP depletion (Yi et al., 2004)
(Figure S3E). However, even during the uncoupler-induced
depolarization, H2O2 caused further inhibition in motility (79.4%
± 1.3% versus 62.4% ± 1.2% of control; n = 21; p < 0.01; lower
plot in Figure S3E), supporting that H2O2 suppressed motility
independent of DJm loss.
H2O2-Induced Mitochondrial Motility Inhibition Is a
Reversible Process
Mitigation of endogenous H2O2 was increasing mitochondrial
motility in neurons where N-acetyl-cysteine was applied, result-

ing in increased mitochondrial velocities after 40 min (Figure 1I).
To further assess the effects of antioxidants on H2O2-induced
mitochondrial motility inhibition in H9c2 cells, we incubated the
Ca2+-depleted cells with H2O2, and after the mitochondrial
motility inhibition was documented (5 min), the extracellular
H2O2 was eliminated by catalase (2,500 IU) and motility was
reassessed at 20 min. As shown in Figure 4A, catalase treatment
reversed H2O2-induced motility decrease (96.4% ± 5.5% of
motility in treated versus 78.4% ± 4.4% in untreated). Again,
treatment with CsA has no effect on the motility inhibition and
its reversibility (Figure 4B), arguing against a role of PTP activation in the process.
p38a Is Required for the H2O2-Induced Mitochondrial
Motility Inhibition
H2O2 was reported to induce many changes in protein phosphorylation and activation of signaling factors mediating phosphoregulation like protein kinase C (Shibukawa et al., 2003),
protein phosphatase 2A (PP2A) (Rao and Clayton, 2002), and
mitogen-activated protein kinases (MAPKs) superfamily through
activation of ASK1 MAP3 kinase (Figure 4C) (Ichijo et al., 1997;
Saitoh et al., 1998). To evaluate whether any of these pathways
were involved here, we screened kinase and phosphatase inhibitors for motility regulation in the presence of H2O2. Neither
okadaic acid (PP1 and PP2A inhibitor) nor staurosporine (PKC
inhibitor) was able to influence on motility inhibition by H2O2.
To selectively inhibit JNK or p38 MAPK kinases, we used
SP600125 or SB202190 in a Ca2+-free condition. H2O2 was
able to decrease motility in both kinase inhibitor untreated
and SP600125-treated cells, but it was ineffective when
SB202190 was used (Figure 4D), suggesting an involvement
of p38.
Four isoforms of p38 exist in mammals (a, b, d, and g). In the
heart, all four isoforms are present (Dingar et al., 2010). However,
in the brain and many other tissues, only p38a and p38b are
expressed (Jiang et al., 1996; Stein et al., 1997). Interestingly,
p38 phosphorylation has recently been implied in the regulation
of ER-mitochondria associations and motility (Li et al., 2015), and
activation of p38a inhibits anterograde fast axonal transport
upon expression of a pathogenic mutation of superoxide dismutase 1 (SOD1) (Morfini et al., 2013). To test whether isoform a
could play a role in motility regulation, we transfected H9c2
with a dominant-negative mutant of p38a (p38aDN), in which
Thr180 and Tyr182 residues were mutated to prevent phosphorylation and activation of the MAPK. Dominant-negative interference with p38a also rendered mitochondrial motility gradually
declining in our recording conditions (21% ± 3% of motility
decay; Figure S2A). H2O2 suppressed the remaining motility to
a smaller extent in p38aDN-expressing cells than in cells transfected with empty vector (EV; Figure 4E).

was able to decrease motility in both kinase inhibitor untreated and SP600125-treated cells, but it was ineffective when SB202190 was used (% of motility decay
of 25 ± 4, 29 ± 4 and 4 ± 3, respectively). *p < 0.002.
(E) Motility decay (calculated as in D) at 8 min after H2O2 addition (black bar) to H9c2 cells transfected with empty vector (EV) or dominant-negative mutant of p38a
(p38aDN) as indicated. *p < 0.002.
(F) Measurement of mitochondrial movements in wild-type (WT) and p38a knockout (p38a / ) MEFs transfected with mitoYFP. Kymograms (lower) before (60 s)
and 8 min after (540 s) H2O2 addition.
(G) Motility decay at 8 min after H2O2 addition (black bar) to mitoYFP-expressing MEFs as in (F). Motility was calculated as in (D). *p < 0.006.
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Mitochondrial motility was then assessed in MEFs lacking
p38a (p38a / ). MEFs in general showed more resistance to
H2O2-induced motility inhibition than hippocampal neurons or
H9c2 cells: to achieve a motility decay of 52.2% ± 7.3% at
time point of 8 min, we increased the H2O2 concentration from
100 to 200 mM. Addition of the same dose of H2O2 to p38a /
MEFs did not cause a decrease of localized mitochondrial movements (Figure 4F) or general mitochondrial motility inhibition (Figure 4G), confirming that p38a is required for the H2O2-induced
motility arrest.
The Motor Adaptor Complex Is Essential for Mediating
the H2O2-Induced Mitochondrial Motility Decay
Mitochondrial movements along microtubules and microfilaments are achieved through an adaptor complex (containing
Miro1/2 and Trak1/2) and motor proteins (kinesins, dyneins,
and myosins). Because the spatial relationship between mitochondria and microtubules is not affected by H2O2 (Figure 2G),
we reasoned that the activity of one of these two components
could be the target of p38 for achieving ROS-induced inhibition
of motility. Kinesin KIF5C has been already described as a target
of p38 (Morfini et al., 2013): phosphorylation of its serine residue
in position 176 regulates cargo transport by promoting disengagement of the motor from microtubule tracks (Padzik et al.,
2016). Kif5B, one of the kinesins responsible for movements of
mitochondria (Tanaka et al., 1998), together with Kif1B and
KLP (Nangaku et al., 1994; Tanaka et al., 2011), belongs to the
same kinesin family as Kif5C (Kanai et al., 2000). Serine 176 is
conserved between KIF5C and KIF5B, and is also found in
KIF1B (Figure S4C). We therefore created a phospho-resistant
mutant of KIF5B by mutagenizing residue 176 to alanine
(KIF5BS176A) and used it to transfect H9c2 cells (Figure S4D).
After exposure to H2O2, H9c2 expressing the phospho-resistant
mutant of KIF5B exhibited approximately the same percentage
of motility decay documented in control cells (55.7% ± 2%
for KIF5BS176A and 60.3% ± 2% for EV-transfected cells;
Figure S4E). Therefore, expression of phospho-resistant
KIF5BS176A was unable to prevent mitochondrial motility inhibition exerted by H2O2.
This kinesin in combination with the FRB-FKBP drug-inducible heterodimer was then employed to determine the involvement of Miro/Trak protein complex in the effect exerted by
H2O2. HA-KIF5B (1-807)-FRB, the truncated KIF5B lacking its
tail domain, which is known to be constitutively active without
interference of regulatory pathways (Kapitein et al., 2010), was
fused to FRB and was co-expressed with TOM20-mCherryFKBP (Chung et al., 2016). Addition of rapalog causes heterodimerization between adjacent FRB and FKBP domains to
directly connect kinesin motor proteins to mitochondria. The
rearrangement of mitochondrial distribution upon rapalog addition is shown in Figure 5A: mitochondria initially accumulated
around the nucleus (150 s) aligned with the microtubular tracks
(240 s; see also Figure S4F), where Kif5B is probably anchored,
and then move to the peripheral tips of the cell, where they
form aggregates (600 s, arrowheads, lower right panel). Cells
untreated with rapalog did not show any change in the
mitochondrial distribution during the same time (Figure 5A, upper panel).

To assess whether the rapalog-induced anchoring to Kif5B
was affecting motility, we quantified the amount of moving
mitochondria (represented as red and green pixels, Figure 5B).
Expression of the anchor components, in the absence of rapalog, did not substantially change it (Figure 5B, first row). In the
same condition, H2O2 caused a decrease in mitochondrial
motility (second row). However, when mitochondria were directly
anchored to KIF5B, H2O2 was unable to induce a decrease in the
motility (Figures 5B, last two rows, 5C, and 5D). Mean traces of
the motility decay for the conditions described above are
shown in Figure 5C. These data suggest that H2O2 targets the
motor adaptor complex via p38a to suppress mitochondrial
movements.
DISCUSSION
This work provides evidence for the control of mitochondrial
motility by ROS, through a p38a-dependent pathway and the
adaptor complex that anchors mitochondria to the microtubular
motor proteins. Both external and internal sources of ROS cause
a decrease in mitochondrial motility in rat hippocampal neurons
and H9c2 cells. This is attained by small amounts of ROS like
25 mM H2O2 and is rapidly reversible. ROS can stop mitochondrial movements independent of [Ca2+]c, a well-known
mitochondrial motility regulator, and of Dcm. Furthermore,
ROS-induced mitochondrial dysfunction or PTP opening is not
involved in H2O2-induced motility decay. Based on genetic and
pharmacological evidence, ROS inhibition of mitochondrial
motility requires a p38a pathway and seems to target specifically
the adaptor complex that links mitochondria to the microtubular
motor proteins.
Due to their polarized and complex functional and structural
organization, neurons need to distribute mitochondria in neurites, to reach areas where their metabolic activity is required
(like synapses) and to easily drive their engulfment and elimination and replacement when they become dysfunctional during
cellular stress. ROS function as intracellular messengers in
long-term potentiation but also represent a source of synaptic
stress, when their elevation is sustained. We here showed that
oxidative stress (H2O2, O2, , menadione, and GSH depletion)
rapidly suppresses mitochondrial velocity in rat hippocampal
neurons in a dose-dependent manner. Importantly, inhibition of
motility was distinguished from ROS-induced mitochondrial
elongation and fragmentation, which are evoked by prolonged/
massive ROS exposure. We have studied the mechanism of
the motility inhibition (see below) and speculate that a separate
ROS-activated pathway engages the mitochondrial fusionfission proteins likely by posttranslational modification, but
establishing this point requires further studies.
To investigate the mechanisms underlying the ROS-induced
mitochondrial motility inhibition, we switched to H9c2 cells that
we had extensively used in previous works to dissect mitochondrial dynamics. ROS likely target functionally relevant SH groups
in proteins, but the number of candidate proteins is high. We
considered three potential mechanisms to decrease mitochondria motility in response to ROS. First, ROS could induce a rise
in [Ca2+]c through sensitization to threshold concentrations of
inositol-1,4,5-trisphosphate (IP3)-linked agonists (Booth et al.,

Cell Reports 21, 1667–1680, November 7, 2017 1675

A

B

C

D

Figure 5. The Adaptor Complex Is Essential for Mediating the H2O2-Induced Mitochondrial Motility Decay
(A) Confocal images of H9c2 cells expressing TOM20-mCherry-FKBP and HA-KIF5B (1-807)-FRB show the distribution of mitochondria (at 0, 150, 240, and 600 s)
with (lower) or without (w/o) (upper) rapalog treatment. Note the rapalog-induced marked conglomeration of mitochondria at the distal tips of the cell at 600 s
(arrowheads).
(B) Confocal images show motility in of H9c2 cells overexpressing mito-kinesin linker at times 0 and 540 s. Where indicated, rapalog and/or H2O2 was applied at
60 s.
(C) Mean traces of motility decay with (solid lines) or w/o (dotted lines) H2O2 addition in the presence (red) or absence (black) of rapalog. Treatments were applied
at 60 s. Schematic representations of adaptor motor complex and the mito-kinesin linker before and after rapalog-induced heterodimerization are shown.
(D) Motility decay 8 min (540 s) after H2O2 (black bar) and rapalog addition. Experiments were as in (C). *p < 0.001.
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2016) and through modulation of ER or plasma membrane Ca2+
transport mechanisms (Bootman et al., 1997; Csordás and Hajnóczky, 2009; Prosser et al., 2011). However, we here showed
that Ca2+ pre-depleted cells also underwent motility decay
upon addition of H2O2 without any rise in [Ca2+]c. Thus, in our
case, ROS can inhibit motility independently of [Ca2+]c.
Conversely, Ca2+-induced motility arrest could involve ROS.
Ca2+ can increase ROS generation by enhancing tricarboxylic
acid cycle and making the mitochondrial redox centers more
reduced (Brand, 2016; Hansford and Zorov, 1998; McCormack
and Denton, 1993) and by opening the PTP (Vercesi et al.,
1997). However, we have shown that Ca2+ does not have to enter
mitochondria to control motility (Yi et al., 2004). Ca2+ could also
act on extramitochondrial enzymes like NADPH oxidase, cytochrome P450, xanthine oxidase, cyclooxygenase, and lipoxygenase to enhance ROS (Kevin et al., 2003; Sauer et al., 2001), or
on mitochondria externally, by activating reductive equivalent
shuttles (Orr et al., 2012). However, the mitochondrial motility inhibition closely follows the [Ca2+]c rise and is dependent on the
EF-hands of Miro, indicating a fairly direct interaction of Ca2+
with the adaptor/motor complex (MacAskill et al., 2009b; Saotome et al., 2008; Wang and Schwarz, 2009; Yi et al., 2004).
Thus, Ca2+ and ROS seem to have privileged mechanisms to
target mitochondrial motility, but they can also engage each
other to regulate motility.
The next potential candidates to mediate ROS-induced mitochondrial motility inhibition were PTP opening and loss of the
mitochondrial membrane potential, because they have been
shown to be outcomes of oxidative stress (De Vos et al., 2007;
Rasola and Bernardi, 2011). But neither PTP inhibition nor predissipation of the membrane potential prevented the H2O2induced motility inhibition.
Lastly, we considered that many effects of ROS are relayed to
changes in protein phosphorylation, and we employed first a
pharmacological approach to test the possible involvement of
protein kinases and phosphatases. From the drugs tested, only
SB202190, an inhibitor of p38, attenuated the motility decay
caused by H2O2. However, SB202190 has been reported to
stimulate ruthenium red-sensitive mitochondrial Ca2+ uptake in
both p38-dependent and -independent manners (Montero
et al., 2002; Szanda et al., 2008). Therefore, we used two independent genetic models to verify whether p38a was involved in
the process of H2O2-induced mitochondrial motility inhibition:
(1) H9c2 cells were transfected with p38aDN, and (2) MEFs ablated of p38a were challenged with H2O2. Both sets of experiments
demonstrated that p38a is required for the H2O2-induced motility
decrease. In a previous work, SB202190-induced motility inhibition was ascribed to an increased mitochondrial Ca2+ uptake
(Chang et al., 2011). However, we documented the H2O2induced motility decrease in Tg-pretreated cells incubated in
the absence of extracellular Ca2+, where no mitochondrial Ca2+
uptake could occur. In addition, H2O2 was unable to induce
inhibition when p38 was targeted, suggesting that p38 activation
in response to ROS might mediate the inhibition of the organellar
movements.
When mitochondria were forced to directly associate to a
motor protein through a drug-induced FRB-FKBP tether, the effect of H2O2 on motility was prevented, suggesting that ROS

target the adaptor complex. Phosphorylation of mitochondrial
and cytosolic substrates has been recently proposed as the
mechanism that drives redistribution of mitochondria during
mitosis (Chung et al., 2016). In that study, phosphorylation drives
detachment of mitochondria + adaptor from motor protein. However, we did not document a change in the association of mitochondria to microtubules upon ROS elevation. This observation
is also an argument against switching of mitochondria to microfilaments or intermediate filaments, which also support mitochondrial positioning (Kuznetsov et al., 1992; Nekrasova et al.,
2011; Pathak et al., 2010; Schwarz and Leube, 2016). Alternative
explanations are that the adaptor might respond to ROS and
p38a activation by relaying an inhibitory signal to the motor proteins or by binding to less active motor proteins.
Mitochondrial motility inhibition is induced by physiologically
relevant doses of H2O2 and is rapidly reversed by removal of
H2O2. This supports the idea that ROS might work as a physiological regulator of mitochondrial distribution, temporally
decelerating the organelles when and where it is required. This
process may enable to recruit additional mitochondria at the
site of ROS elevation, and serve both ROS scavenging and propagation of ROS production, which may have relevance in pathophysiological conditions. Finally, in line with recent findings on
ROS/Ca2+ communication at mitochondria-ER contact sites
(Booth et al., 2016) and on the involvement of mitochondrial respiratory complex I- and III-originated ROS in ER-stress-induced
caspase activation (Brand et al., 2016), a Ca2+-induced rise in
mitochondrial ROS could serve as a signal to stop mitochondria
in proximity to ER to establish new contact sites to serve as
signaling modulators. Thus, our findings offer some clues relevant for mitochondrial quality control and for both cell survival
and death signaling.
In the final phase of the writing of this manuscript, a paper
came out on oxidative stress (paraquat and H2O2)-induced
motility inhibition in fly neurons (Liao et al., 2017). Thus, ROS
control motility both in fly and in mammalian cells, although in
fly, the ROS effect seems to be mediated via [Ca2+]c elevation,
whereas in mammalian cells, ROS can engage robust motility inhibition even independent of Ca2+. Liao et al. (2017) speculated
that elevated [Ca2+]c acts through Miro1, a mitochondrial anchor
for motors, and we provided experimental evidence that the
motor adaptor complex is needed for the inhibitory effect of
ROS. Interestingly, in fly, JNK was also implicated in the motility
inhibition, whereas in mammalian cells, p38a is required and JNK
is dispensable. p38a is present in fly but was not investigated by
Liao et al. (2017). From the two studies, an evolutionarily
conserved ROS phenotype emerges in motility that uses species-specific underlying mechanisms to target the mitochondrial
motor adaptor complex.
EXPERIMENTAL PROCEDURES
Detailed protocols are available in the Supplemental Experimental
Procedures.
Cell Culture, Loading, and Transfection
Primary hippocampal neurons, H9c2 myoblast cells, and MEF cells were prepared, transfected, and treated as in Gerencser and Nicholls (2008), Nguyen
et al. (2014), and Yi et al., (2004). All procedures involving rats were carried
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out according to the local animal care and use committee (Egyetemi Allatkiserleti Bizottsag) guidelines.

Brickley, K., Smith, M.J., Beck, M., and Stephenson, F.A. (2005). GRIF-1 and
OIP106, members of a novel gene family of coiled-coil domain proteins: association in vivo and in vitro with kinesin. J. Biol. Chem. 280, 14723–14732.

Fluorescence and Confocal Imaging
Time-lapse fluorescence microscopy of hippocampal neurons was performed
on an Olympus IX81, while measurements [Ca2+]c and/or mitochondrial
motility in H9c2 and MEFs were carried out on an Olympus IX70 with UAPO
403 oil 1.3 NA lens. Confocal imaging was performed using a Radiance
2100 (Bio-Rad).

Brough, D., Schell, M.J., and Irvine, R.F. (2005). Agonist-induced regulation of
mitochondrial and endoplasmic reticulum motility. Biochem. J. 392, 291–297.

Evaluation of Mitochondrial Motility
Mitochondrial velocities were measured as optical flow (Gerencser and Nicholls, 2008), whereas motility in H9c2 cells and MEFs was evaluated as
described previously (Saotome et al., 2008; Yi et al., 2004).
Statistical Analysis
All experiments were performed with at least three different preparations. Data
are presented mean ± SEM, and significance of difference was calculated by
t test unless otherwise indicated. For measurements of mitochondrial velocities
in neurons, nine cells were pooled from each preparation, and the results were
tested using ANOVA (Dunnett’s post hoc test, treatment versus control, independently for the two time points). For measurements of DJp in neurons,
data are % of baseline fluorescence (n = 81, 107, and 70 cells for control,
H2O2, and menadione, respectively). For measurements of mitochondrial
motility in H9c2 cells and MEFs for each condition, 7–10 cells/preparation
were evaluated.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and four figures and can be found with this article online at https://doi.org/
10.1016/j.celrep.2017.10.060.

Chada, S.R., and Hollenbeck, P.J. (2004). Nerve growth factor signaling regulates motility and docking of axonal mitochondria. Curr. Biol. 14, 1272–1276.
Chang, K.T., Niescier, R.F., and Min, K.T. (2011). Mitochondrial matrix Ca2+ as
an intrinsic signal regulating mitochondrial motility in axons. Proc. Natl. Acad.
Sci. USA 108, 15456–15461.
Chung, J.Y., Steen, J.A., and Schwarz, T.L. (2016). Phosphorylation-induced
motor shedding is required at mitosis for proper distribution and passive inheritance of mitochondria. Cell Rep. 16, 2142–2155.
Csordás, G., and Hajnóczky, G. (2009). SR/ER-mitochondrial local communication: calcium and ROS. Biochim. Biophys. Acta 1787, 1352–1362.
Das, S., Hajnóczky, N., Antony, A.N., Csordás, G., Gaspers, L.D., Clemens,
D.L., Hoek, J.B., and Hajnóczky, G. (2012). Mitochondrial morphology and dynamics in hepatocytes from normal and ethanol-fed rats. Pflugers Arch. 464,
101–109.
De Vos, K.J., Chapman, A.L., Tennant, M.E., Manser, C., Tudor, E.L., Lau, K.F.,
Brownlees, J., Ackerley, S., Shaw, P.J., McLoughlin, D.M., et al. (2007). Familial amyotrophic lateral sclerosis-linked SOD1 mutants perturb fast axonal
transport to reduce axonal mitochondria content. Hum. Mol. Genet. 16,
2720–2728.
Dingar, D., Merlen, C., Grandy, S., Gillis, M.A., Villeneuve, L.R., Mamarbachi,
A.M., Fiset, C., and Allen, B.G. (2010). Effect of pressure overload-induced hypertrophy on the expression and localization of p38 MAP kinase isoforms in the
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Yi, M., Weaver, D., and Hajnóczky, G. (2004). Control of mitochondrial motility
and distribution by the calcium signal: a homeostatic circuit. J. Cell Biol. 167,
661–672.

Vesce, S., Jekabsons, M.B., Johnson-Cadwell, L.I., and Nicholls, D.G. (2005).
Acute glutathione depletion restricts mitochondrial ATP export in cerebellar
granule neurons. J. Biol. Chem. 280, 38720–38728.

Yuan, H., Gerencser, A.A., Liot, G., Lipton, S.A., Ellisman, M., Perkins, G.A.,
and Bossy-Wetzel, E. (2007). Mitochondrial fission is an upstream and
required event for bax foci formation in response to nitric oxide in cortical neurons. Cell Death Differ. 14, 462–471.

Wang, X., and Schwarz, T.L. (2009). The mechanism of Ca2+ -dependent
regulation of kinesin-mediated mitochondrial motility. Cell 136, 163–174.

Zucker, R.S. (1999). Calcium- and activity-dependent synaptic plasticity. Curr.
Opin. Neurobiol. 9, 305–313.

1680 Cell Reports 21, 1667–1680, November 7, 2017

